Skip to content
sellWeak

Matthew Campobasso sold $6,032 of ENFN

General Counsel at Enfusion, Inc.. 674 shares at an average of $8.95, traded Oct 22, 2024, filed Oct 24, 2024.

Warning score
15
Value
$6,032
674 shares
Holdings after
53,627
-1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Officer
    +15
  • Trade size
    $6k at market
    0
  • Share of holdings sold
    Sold 1.2% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001104659-24-111160, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Oct 22, 2024SOpen-market sale
Class A Common Stock
-674$8.95$6,03253,627Oct 24, 2024

Related signals

Other insiders at Enfusion, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
36Weak
ENFNsell 6
Enfusion, Inc.
Bronwen Bastone
Chief People Officer
$36k
3,126 shares
-1%
51Moderate
ENFNsell 6
Enfusion, Inc.
Oleg Movchan
Chief Executive Officer
$130k
11,452 shares
-2%
30Weak
ENFNsell 6
Enfusion, Inc.
Matthew Campobasso
General Counsel
$19k
1,695 shares
-2%
44Moderate
ENFNsell 6
Enfusion, Inc.
Bradley Herring
Chief Financial Officer
$53k
4,645 shares
-1%
30Weak
ENFNsell 6
Enfusion, Inc.
Valeria Gutowski
Chief Accounting Officer
$6,165
542 shares
-1%
46Moderate
ENFNsell 6
Enfusion, Inc.
Neal Pawar
Chief Operating Officer
$166k
14,560 shares
-1%
30Weak
ENFNsell 6
Enfusion, Inc.
Valeria Gutowski
Chief Accounting Officer
$14k
1,233 shares
-2%
30Weak
ENFNsell 6
Enfusion, Inc.
Bronwen Bastone
Chief People Officer
$24k
2,064 shares
-1%
45Moderate
ENFNsell 6
Enfusion, Inc.
Oleg Movchan
Chief Executive Officer
$32k
2,790 shares
-0%
30Weak
ENFNsell 6
Enfusion, Inc.
Matthew Campobasso
General Counsel
$12k
1,081 shares
-1%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Matthew Campobasso sold $6,032 of ENFN | InsiderTell